198 related articles for article (PubMed ID: 19279296)
1. D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons.
Lalley PM
Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1829-36. PubMed ID: 19279296
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects on the phrenic motor pathway attributed to dopamine-D1 and -D3/D2 receptor activation.
Lalley PM; Mifflin SW
Respir Physiol Neurobiol; 2012 Apr; 181(2):183-93. PubMed ID: 22465544
[TBL] [Abstract][Full Text] [Related]
3. D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat.
Lalley PM
Am J Physiol Regul Integr Comp Physiol; 2005 Jul; 289(1):R45-51. PubMed ID: 15705800
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
Bergman J; Rosenzweig-Lipson S; Spealman RD
J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
[TBL] [Abstract][Full Text] [Related]
5. Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: evidence for involvement in certain types of ventilatory disturbances.
Lalley PM
Am J Physiol Regul Integr Comp Physiol; 2003 Dec; 285(6):R1287-304. PubMed ID: 12881202
[TBL] [Abstract][Full Text] [Related]
6. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
7. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
8. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
David HN; Abraini JH
Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
[TBL] [Abstract][Full Text] [Related]
9. Dopamine1 receptor agonists reverse opioid respiratory network depression, increase CO2 reactivity.
Lalley PM
Respir Physiol Neurobiol; 2004 Feb; 139(3):247-62. PubMed ID: 15122991
[TBL] [Abstract][Full Text] [Related]
10. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Zackheim JA; Abercrombie ED
Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine D1 receptor full agonists in rats trained to discriminate SKF 38393.
Gleason SD; Witkin JM
Behav Pharmacol; 2004 Feb; 15(1):85-9. PubMed ID: 15075630
[TBL] [Abstract][Full Text] [Related]
12. Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Izquierdo-Claros RM; del Boyano-Adánez M; Arilla-Ferreiro E
J Neurosci Res; 2000 Oct; 62(1):91-8. PubMed ID: 11002291
[TBL] [Abstract][Full Text] [Related]
13. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
14. D1 and D2 receptor-mediated dopaminergic modulation of visual responses in cat dorsal lateral geniculate nucleus.
Zhao Y; Kerscher N; Eysel U; Funke K
J Physiol; 2002 Feb; 539(Pt 1):223-38. PubMed ID: 11850515
[TBL] [Abstract][Full Text] [Related]
15. Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia.
Waszczak BL; Martin LP; Finlay HE; Zahr N; Stellar JR
J Pharmacol Exp Ther; 2002 Mar; 300(3):850-61. PubMed ID: 11861790
[TBL] [Abstract][Full Text] [Related]
16. The effects of dopamine and dopamine receptor agonists on the phototransduction cascade of frog rods.
Nikolaeva DA; Astakhova LA; Firsov ML
Mol Vis; 2019; 25():400-414. PubMed ID: 31523118
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism.
Podda MV; Riccardi E; D'Ascenzo M; Azzena GB; Grassi C
Neuroscience; 2010 May; 167(3):678-90. PubMed ID: 20211700
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
19. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
[TBL] [Abstract][Full Text] [Related]
20. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]